Duke CT Surgery Outcomes Group

Resident-run cardiothoracic outcomes research group @DukeSurgery

[Sammy Halpern @sehalpern5]

Excited for #ISHLT2021 this weekend!

Tune in on Wed April 28th from 11:45-11:50 EDT to hear our #MiniOral discussing use of 🫁 allografts w/ “extreme” ischemic times for txp

@DukeCTOutcomes @DukeSurgery @DukeCTSurgery @mghartwigmd @SJKesseli @DanaeOlaso @brandi_bottiger

[Oliver K. Jawitz MD @ojawitzMD]

Thank you to
@STS_CTsurgery for highlighting our study in this #STS2021 press briefing:

🔹Sex Disparities on Coronary Artery Bypass Grafting Techniques

@DukeSurgery @DukeCTSurgery @DCRINews @DukeSurgRes @DukeCTOutcomes

https://t.co/LPnfIjiIEe

[Oliver K. Jawitz MD @ojawitzMD]

Just published in @SurgJournal: our @STS_CTsurgery analysis of Ravitch vs Nuss repair of pectus excavatum

🔹No difference peri-op complications after adjustment
🔹Generally a low vol procedure for CT surgeons

@DukeCTSurgery @DukeSurgery @DCRINews

https://t.co/M6l10URBWh

[Oliver K. Jawitz MD @ojawitzMD]

Our post-hoc analysis of LEVO-CTS now published in @AmericanHeartJ

🔹No association between levosimendan and post-op AKI in low EF patients undergoing cardiac surgery

@DCRINews @DukeSurgery @DukeCTSurgery @RenatoDLopes1 @DukeCTOutcomes @vigneshr11

[Oliver K. Jawitz MD @ojawitzMD]

Just published @Transpl_Int: Center volume and primary graft dysfunction after lung transplant

🔹Near linear association b/w ⬆️ center volume and ⬇️ likelihood of grade 3 PGD
🔹Improved survival after PGD with ⬆️ volume at low and medium volume centers

https://t.co/TdlK9M1UeN

[Oliver K. Jawitz MD @ojawitzMD]

Just published in @AATSJournals #JTCVS: Factors associated with short- versus long-term survival after lung transplant

🔹Minimal overlap between factors associated with 1- and 10-year survival
🔹Widely used LAS not associated with long-term survival

https://t.co/76PVjHqBJJ

[Oliver K. Jawitz MD @ojawitzMD]

Just published @AmericanHeartJ: Post-hoc analysis of LEVO-CTS trial examining association between levosimendan and AKI in low EF cardiac surgery patients

🔹Levosimendan NOT associated with risk of AKI

@DCRINews @DukeSurgery @DukeCTSurgery @DukeHeartCenter @Duke_Anesthesia

[Duke CT Surgery Outcomes Group @DukeCTOutcomes]

@maraantonoff @MDAndersonNews @UTH_CVSurgery @IanCBostock1 @TSRA_official @tssmn @ThoracicStudent @WomenInThoracic @MDAndersonLib @TECoG_ @soraya_voigtMD your life’s work

[Oliver K. Jawitz MD @ojawitzMD]

Amazing work by @sehalpern5 and team!

Paradigm-shifting work introducing a new way to evaluate the performance of OPOs - an integral aspect of the US transplant system #TransplantTwitter

@DukeSurgery @DukeCTSurgery @DukeCTOutcomes @CRTP_DukeSOM @amjtransplant @tssmn

[Sammy Halpern @sehalpern5]

🔥Hot off the press🔥 We proposed a new 3-tier system for OPO performance evaluation in #LungTxp out now in @amjtransplant. Huge thanks & congrats to the whole team! @ojawitzMD @vigneshr11 @AshleyYJChoi @mghartwigmd @CMSGov @UNOSNews

https://t.co/t3HhrKITVU

[Sameer Hirji @Hirji1987]

Outstanding editorial comment by @ojawitzMD from @DukeSurgery @DukeCTSurgery @DCRINews on our Explant TAVR paper.
👇👇
https://t.co/Hnbu1e2npX

[Duke CT Surgery Outcomes Group @DukeCTOutcomes]

Great work @JulieDoberne and team! @annalsthorsurg @UNOSNews @DukeSurgery @WomenInThoracic

[Julie Doberne MD PhD FACS @JulieDoberne]

HIV+ heart transplant recipients fared no worse than HIV- counterparts in 30-d, 5-yr survival. HIV+ should not, in isolation, be an absolute contraindication to OHT. Pub here: https://t.co/xYRXnP6Vzl

@JacobNiall @DukeHeartCenter @DukeCTSurgery @benbryner @ojawitzMD @vigneshr11

[Sammy Halpern @sehalpern5]

Online now @amjtransplant! Our lung transplant experience during the early #COVID19 pandemic. https://t.co/2lWpr6O11o

✅pre-txp testing

✅risk factor screening

✅local procurements

⬆️txp volume

@mghartwigmd @DanaeOlaso @DukeSurgery @DukeCTSurgery

[Neel Prabhu @Neel_Prabhu]

Now in press at Perfusion, we describe an operation strategy (STAR perfusion) that could decrease ischemic time during complex Norwood procedures by over 2 fold. Excited to see this out, thanks to the guidance of @TurekPedHearts! @DukeCTOutcomes https://t.co/bTkLc56WWl

[Nellie Farrow @nelfarrow]

Excited to see our NCDB analysis on the impact of age of surgical outcomes for locally advanced esophageal cancer available online @annalsthorsurg https://t.co/JcMh2IVcEe Thanks to @vigneshr11 @ojawitzMD @BTongMD and Drs D'Amico & Harpole for their work on this.

[Duke CT Surgery Outcomes Group @DukeCTOutcomes]

Thanks: @BTongMD @ojawitzMD @vigneshr11 @DukeSurgRes @DukeCTSurgery @ECUSurgery and Drs. Harpole and D'Amico

[Duke CT Surgery Outcomes Group @DukeCTOutcomes]

Congratulations to @AJustinRucker2, @krisrho93, and @soraya_voigtMD on their abstracts accepted to @AATSHQ #ITSOS2020!

[Duke CT Surgery Outcomes Group @DukeCTOutcomes]

@krisrho93 will present a poster on disparities in guideline-concordant adjuvant chemo in node-positive esophageal cancer. @soraya_voigtMD's poster examines tumor size and adjuvant chemo in node-negative esophageal cancer.

[Oliver K. Jawitz MD @ojawitzMD]

Check out our contribution in the new special #ERASCardiac issue of @CritCareClinics:

🔹How to start an #ERAS Cardiac program

@JudsonBWilliams @danengelmanmd @DukeCTSurgery @DukeHeartCenter @DukeSurgery @DCRINews @WakeMed

https://t.co/XQbaUhHRGy